HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Biomarker evaluation as a potential cause of gender differences in obesity paradox among patients with STEMI.

AbstractBACKGROUND:
Obesity with its worldwide growing prevalence is an established cardiovascular risk factor with increased morbidity and mortality. However, the phenomenon, that mild to moderate obesity seems to represent a protective effect on diseases has been termed the "obesity paradox".
METHODS:
We retrospectively assessed 529 patients (72.6% male, mean age 59.7±12.7years) admitted with ST-elevation myocardial infarction (STEMI). The female and male study populations were separated into four body mass index (BMI) groups: ≤24.9kg/m(2), 25.0-29.9kg/m(2), 30.0-34.9kg/m(2) and ≥35.0kg/m(2). Blood samples of high-density lipoprotein cholesterol (HDL-c) and low-density lipoprotein cholesterol (LDL-c) were analyzed.
RESULTS:
With increasing BMI group the rate of major adverse cardiac events (MACE) decreased in all patients (test for trend p=0.041). No gender difference between MACE and BMI could be noticed (p=0.16). A higher risk for MACE was indicated in group BMI ≤18.5kg/m(2) in comparison to group BMI 25.0-29.9kg/m(2) (OR: 7.93; 95% CI: 1.75-35.89; p=0.0091), whereas group BMI 30.0-34.9kg/m(2) was significant associated with a lower risk in comparison to group BMI 25.0-29.9kg/m(2) (OR: 0.65; 95% CI: 0.21-1.96; p=0.044). An association between HDL-c (p=0.55) or LDL-c (p=0.10) and MACE could not be detected.
CONCLUSION:
The study demonstrates that patients with STEMI and a BMI of 30.0-34.9kg/m(2) have a decreased risk for MACE compared to patients with normal BMI. No gender related differences were indicated. An association between MACE and lipoproteins could not be detected.
AuthorsStefan Baumann, Johanna Koepp, Tobias Becher, Aydin Huseynov, Katharina Bosch, Michael Behnes, Christian Fastner, Ibrahim El-Battrawy, Matthias Renker, Siegfried Lang, Christel Weiß, Martin Borggrefe, Ralf Lehmann, Ibrahim Akin
JournalCardiovascular revascularization medicine : including molecular interventions (Cardiovasc Revasc Med) Vol. 17 Issue 2 Pg. 88-94 (Mar 2016) ISSN: 1878-0938 [Electronic] United States
PMID26895953 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier Inc. All rights reserved.
Chemical References
  • Biomarkers
  • Cholesterol, HDL
  • Cholesterol, LDL
Topics
  • Aged
  • Biomarkers (blood)
  • Body Mass Index
  • Chi-Square Distribution
  • Cholesterol, HDL (blood)
  • Cholesterol, LDL (blood)
  • Female
  • Humans
  • Logistic Models
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Nutritional Status
  • Obesity (blood, complications, diagnosis, physiopathology)
  • Odds Ratio
  • Percutaneous Coronary Intervention (adverse effects)
  • Protective Factors
  • Retrospective Studies
  • Risk Factors
  • ST Elevation Myocardial Infarction (diagnosis, etiology, therapy)
  • Sex Factors
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: